BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12490547)

  • 1. Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
    Quaschning T; Ruschitzka F; Stallmach T; Shaw S; Morawietz H; Goettsch W; Hermann M; Slowinski T; Theuring F; Hocher B; Lüscher TF; Gassmann M
    FASEB J; 2003 Feb; 17(2):259-61. PubMed ID: 12490547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin.
    Traupe T; D'Uscio LV; Muenter K; Morawietz H; Vetter W; Barton M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():13S-15S. PubMed ID: 12193045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo interaction of nitric oxide and endothelin.
    Hocher B; Schwarz A; Slowinski T; Bachmann S; Pfeilschifter J; Neumayer HH; Bauer C
    J Hypertens; 2004 Jan; 22(1):111-9. PubMed ID: 15106802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of big endothelin-1-induced diuresis and natriuresis : role of ET(B) receptors.
    Hoffman A; Abassi ZA; Brodsky S; Ramadan R; Winaver J
    Hypertension; 2000 Mar; 35(3):732-9. PubMed ID: 10720587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta.
    Loomis ED; Sullivan JC; Osmond DA; Pollock DM; Pollock JS
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1058-64. PubMed ID: 16144972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.
    Deuchar GA; Docherty A; MacLean MR; Hicks MN
    Br J Pharmacol; 2002 Feb; 135(4):1060-8. PubMed ID: 11861335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.
    Kalk P; Mach A; Thone-Reineke C; Godes M; Heiden S; Sharkovska Y; von Websky K; Relle K; Hocher B
    Can J Physiol Pharmacol; 2008 Aug; 86(8):541-5. PubMed ID: 18758502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice.
    d'Uscio LV; Barton M; Shaw S; Lüscher TF
    Cardiovasc Res; 2002 Feb; 53(2):487-95. PubMed ID: 11827700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
    Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
    Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries.
    Liang F; Glascock CB; Schafer DL; Sandoval J; Cable L; Melvin L; Hartman JC; Pitts KR
    Can J Physiol Pharmacol; 2010 Aug; 88(8):840-9. PubMed ID: 20725142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice.
    Quaschning T; Koçak S; Bauer C; Neumayer HH; Galle J; Hocher B
    Nephrol Dial Transplant; 2003 Mar; 18(3):479-83. PubMed ID: 12584267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-type specific interaction of endothelin and the nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-transgenic mice.
    Slowinski T; Kalk P; Christian M; Schmager F; Relle K; Godes M; Funke-Kaiser H; Neumayer HH; Bauer C; Theuring F; Hocher B
    J Physiol; 2007 Jun; 581(Pt 3):1173-81. PubMed ID: 17395629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.
    Virdis A; Duranti E; Rossi C; Dell'Agnello U; Santini E; Anselmino M; Chiarugi M; Taddei S; Solini A
    Eur Heart J; 2015 Apr; 36(13):784-94. PubMed ID: 24578389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia.
    MacLean MR; McCulloch KM
    Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis.
    Barton M; Vos I; Shaw S; Boer P; D'Uscio LV; Gröne HJ; Rabelink TJ; Lattmann T; Moreau P; Lüscher TF
    J Am Soc Nephrol; 2000 May; 11(5):835-845. PubMed ID: 10770961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
    Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
    Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between nitric oxide and endogenous vasoconstrictors in control of renal blood flow.
    Berthold H; Just A; Kirchheim HR; Ehmke H
    Hypertension; 1999 Dec; 34(6):1254-8. PubMed ID: 10601127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
    Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
    Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant erythropoietin alters the flow-dependent vasodilatation of in vitro perfused rat mesenteric arteries with unbalanced endothelial endothelin-1 / nitric oxide ratio.
    Barhoumi T; Jallat I; Berthelot A; Laurant P
    Can J Physiol Pharmacol; 2011 Jun; 89(6):435-43. PubMed ID: 21777087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.